Idorsia Ltd
Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.
IDIA | SW
Overview
Corporate Details
- ISIN(s):
- CH0363463438 (+2 more)
- LEI:
- 506700XOVZUB107S5720
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 91, 4123 Allschwil
- Website:
- https://www.idorsia.com/index
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Idorsia Ltd is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines. The company focuses on building a diversified and balanced clinical development pipeline to transform therapeutic options for patients. Its research and development efforts target a range of conditions, with a primary focus on central nervous system (CNS), cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia aims to challenge existing medical paradigms by creating novel treatments that can significantly improve patient outcomes. The company also provides a dedicated portal with scientific information and educational resources for healthcare professionals and patients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Idorsia Ltd and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Idorsia Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Idorsia Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Non-Executive member | Buy | None | 98,179.90 CHF |
| 2022-05-10 | N/A | Non-Executive member | Buy | None | 109,660.30 CHF |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
